Related Experiment Video
Updated: Jul 12, 2026
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Proventil HFA prevents exercise-induced bronchoconstriction in children.
G L Colice1, N M Klinger, B P Ekholm
13M Pharmaceuticals, St. Paul, Minnesota 55144-1000, USA.
Summary
Short-acting inhaled beta2-agonists effectively prevent exercise-induced bronchoconstriction (EIB) in children. Hydrofluoroalkane-134a (HFA) albuterol demonstrated equal effectiveness to chlorofluorocarbon (CFC) albuterol and superior effectiveness compared to placebo in protecting against EIB.
Area of Science:
- Pediatric Pulmonology
- Respiratory Medicine
- Pharmacology
Background:
- Exercise-induced bronchoconstriction (EIB) is a common condition in children with asthma.
- Short-acting inhaled beta2-agonists are frequently used for EIB prevention.
- Previous formulations used chlorofluorocarbons (CFCs), which are being phased out.
Purpose of the Study:
- To compare the efficacy of hydrofluoroalkane-134a (HFA) albuterol with CFC albuterol formulations and placebo.
- To evaluate the effectiveness of these treatments in preventing EIB in asthmatic children.
Main Methods:
- A randomized, single-blind, placebo-controlled, four-period crossover study.
- Involved 6-11 year old asthmatic children.
- Administered HFA albuterol, two CFC albuterol products, or placebo 30 minutes before exercise challenge.
- Monitored spirometry (FEV1) and vital signs post-exercise.
Main Results:
- All active albuterol treatments (HFA and CFC) were significantly more effective than placebo in preventing EIB.
- The protective effect against EIB was similar across all three active treatments.
- Fewer patients experienced a significant fall in FEV1 (>20%) with active treatments compared to placebo.
- No significant differences in heart rate, blood pressure, or ECG intervals were observed between active treatments.
Conclusions:
- HFA albuterol is a safe and effective alternative to CFC albuterol for preventing EIB in children.
- HFA albuterol provides significant protection against exercise-induced bronchoconstriction, comparable to older CFC formulations.
- This study supports the use of HFA albuterol as a preferred option for EIB prevention in pediatric asthma management.
Related Concept Videos
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
01:24Antiasthma Drugs: Methylxanthines
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
01:30Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:30Asthma-IV: Nursing Management
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...